Bio-Techne Corp is on the Cruelty Free Investing list because it does animal testing for some of their medical products and clinical research.
Biological Activity of MK 801 maleate – A potent, selective and non-competitive NMDA receptor antagonist. Acts by binding to a site located within the NMDA associated ion channel and thus prevents Ca2+ flux. An effective anti-ischemic agent in several animal models.
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology products and clinical diagnostic controls. It operates through three segments include: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment is a suppliers of specialized proteins, such as cytokines, growth factors, immunoassays, antibodies and related reagents, to the biotechnology research community. The Clinical Controls segment develops and manufactures controls and calibrators for instruments in the global clinical market. The Protein Platforms segment develops, manufactures and sells tools to make protein analysis simpler, more quantitative and reproducible. The company was founded on July 17, 1981 and is headquartered in Minneapolis, MN. [Source: MarketWatch]